Alzheimer's disease

News

Dismay but little surprise as NICE rejects Alzheimer's drugs

Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back once again.

News

NewAmsterdam says lead drug may have Alzheimer's role

NewAmsterdam has said that an oral drug it is developing to lower cholesterol has shown early efficacy as a preventive therapy for Alzheimer's.

News

RFK Jr spreading 'harmful myths' on Alzheimer's research

The Alzheimer's Association has hit out at "inaccurate and dangerous fabrications" by HHS Secretary Robert F Kennedy Jr about NIH dementia research.

News

Sanofi makes Alzheimer's play with Vigil takeover

Sanofi bids to add a drug candidate for Alzheimer's disease to its neurology pipeline via the acquisition of US biotech Vigil Neuroscience.

News

FDA clears first blood test for Alzheimer's disease

The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis.

R&D

Shifting paradigms of clinical trial design accelerate CNS R...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed.

Dismay but little surprise as NICE rejects Alzheimer's drugs

NewAmsterdam says lead drug may have Alzheimer's role

RFK Jr spreading 'harmful myths' on Alzheimer's research

Sanofi makes Alzheimer's play with Vigil takeover

FDA clears first blood test for Alzheimer's disease

Shifting paradigms of clinical trial design accelerate CNS R...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's disease

Editor's Picks